News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
GateKeeper USA, Inc. Announced Today It Has Executed a Letter of Intent to Acquire BioAvenge
February 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GAITHERSBURG, Md.--(BUSINESS WIRE)--GateKeeper USA, Inc. (Pink Sheets:GTKP), announced today, is has executed a Letter of Intent for the acquisition of Maryland based, BioAvenge. Specific terms, that are being contemplated, were not disclosed.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies
June 30, 2025
·
2 min read
·
Dan Samorodnitsky
Alzheimer’s disease
Alzheimer’s Deals Surged 780% After Leqembi, Kisunla Broke Approval Stalemate
June 30, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
June 30, 2025
·
1 min read
·
Tristan Manalac